LOWE CHRISTOPHER P. 4
4 · Cortexyme, Inc. · Filed Nov 16, 2021
Insider Transaction Report
Form 4
Cortexyme, Inc.CRTX
LOWE CHRISTOPHER P.
Chief Financial Officer
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2021-11-16−30,000→ 103,294 totalExercise: $2.23Exp: 2028-11-27→ Common Stock (30,000 underlying) - Exercise/Conversion
Common Stock
2021-11-16$2.23/sh+30,000$66,900→ 90,000 total
Footnotes (1)
- [F1]The option will vest as to 25% of the shares on November 15, 2019, with the remaining 75% of shares vesting in equal monthly installments beginning on December 15, 2019 and ending on November 15, 2022.